HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contrast media for left ventricular angiography. A comparison between Cardio-Conray and iopamidol.

Abstract
Forty consecutive patients with coronary artery disease undergoing left ventricular angiography took part in a randomised double blind trial comparing a conventional contrast medium sodium meglumine iothalamate (Cardio-Conray) with the low osmolar agent iopamidol. Iopamidol produced a smaller rise in heart rate and a smaller fall in left ventricular systolic pressure, but the changes in left ventricular and diastolic pressure and maximum rate of change of pressure (dP/dt max) were not different. The numbers of extrasystoles per minute for five minutes after ventriculography were similar in both groups except for the first 15 seconds, when the number of extrasystoles was increased in the iopamidol group. The frequency and magnitude of symptoms (heat, angina, headache, nausea) were significantly different in two groups. Iopamidol caused less haemodynamic disturbance than Cardio-Conray, although the improvement is small and offers no advantage in reducing symptoms or extrasystoles.
AuthorsD J Gwilt, R E Nagle
JournalBritish heart journal (Br Heart J) Vol. 51 Issue 4 Pg. 427-30 (Apr 1984) ISSN: 0007-0769 [Print] England
PMID6200129 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Contrast Media
  • Iothalamic Acid
  • Iopamidol
  • Iothalamate Meglumine
Topics
  • Angiocardiography
  • Cardiac Complexes, Premature (chemically induced)
  • Clinical Trials as Topic
  • Contrast Media (adverse effects)
  • Coronary Disease (diagnostic imaging)
  • Double-Blind Method
  • Female
  • Heart Rate (drug effects)
  • Hemodynamics (drug effects)
  • Humans
  • Iopamidol
  • Iothalamate Meglumine (adverse effects)
  • Iothalamic Acid (adverse effects, analogs & derivatives)
  • Male
  • Middle Aged
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: